CLINICAL_TRIALS
trial_result
· 2018-02-20
Clinical Trial Update: Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine [Phase 3]
Summary
Phase 3 trial assessing tolerability of depot injections of buprenorphine for opioid use disorder has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indivior Inc. | Conditions: Opioid Dependence, Opioid Related Disorders | Phase 3 | Status: COMPLETED | Results posted: 2018-02-20